Apexigen racks up $73 mln


Apexigen Inc, a biopharmaceutical company, has closed its Series B and Series C funding rounds at a total of $73 million. Decheng Capital led the $15 million Series B round while 3E Bioventures Capital, Virtus Inspire Ventures and SV Tech Ventures led the $58 million Series C round.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.